维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Brenner HH"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cardiorenal end points in atrial of aliskiren for type 2 diabetes显示文摘	Parving HH Brenner BM McMurray J J	2012	N Engl J Med2012，367，23：	1
2	Cardiorenal end points in a trial of aliskiren for type 2 diabetes显示文摘	Parring HH Brenner BM McMurray JJ	2012	N Engl J Med2012，367，23：	1
3	Cardiorenal end point in a trial of aliskiren for type 2 diabetes显示文摘	Parving HH Brenner BMiMcMurray JJ	2012	N Engl J Med2012，367，23：	1
4	Cardiorenal and points in a trim of aliskiren for type 2 diabetes 显示文摘	Parving HH Brenner BM McMurray JJ	2012	N Engl J Med2012，367，23：	1
5	Cardiorenal end points in a trial of aliskiren for type 2 diabetes显示文摘	Parving HH Brenner BM McMurray JJ		0，，23：	1
6	Baseline characteristics in the aliskiren trial in type 2 diabetes using cardio-renal endpoints ( ALTITUDE ) 显示文摘	Parving HH Brenner BM McMurray J/V	2012	J Renin Angiotensin Aldosterone Syst2012，13，3：	1
7	Aliskiren Trial in Type 2 Dia- betes Using Cardio-Renal Endpoints (ALTITUDE) rationale and study design 显示文摘	Parring HH Brenner BM McMurray JJ	2009	Nephml Dial Transplant2009，24，5：	1
8	Cardiorenal end points in a trial of aliskiren for type 2 dlnhetes显示文摘	Parving HH Brenner BM MeMurray JJ	2012	N Engl J Med2012，367，23：	1
9	Aliskiren trial in type 2 diabetes using cardio-renal endpoints ( ALTI- TUDE): rationale and study design 显示文摘	Parring HH Brenner BM McMurray JJ	2009	Nephrol Dial Transplant2009，24，5：	1
10	Plasmodium chabaudi malaria:protective immunization with surface membranes of infected erythrocytes显示文摘	Wunderlich F Brenner HH Helwig M	1988	Infect Immun1988，56，12：	1
11	Cardiorenal end points in a trial of aliskiren for type 2 diabetes显示文摘	Parving HH Brenner BM McMurrayJJ	2012	N Engl J Med2012，367，23：	1
12	Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE):rationale and study design 显示文摘	Parving HH Brenner BM McMurray J J	2009	Nephrol Dial Transplant2009，24，5：	1
13	Cardiorenal end points in a trial of aliskiren for type 2 diabetes显示文摘	Parring HH Brenner BM McMurrayJJ	2012	N EnglJ Med2012，367，：	1
14	Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study 显示文摘	Parving HH Mogensen CE Thomas MC Brenner BM Cooper ME	2005	QJM2005，98，2：	1
15	Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy显示文摘	Brenner BM Cooper ME de Zeeuw D Keane WF Mitch WE Parving HH Remuzzi G Snapinn SM Zhang Z Shahinfar S RENAAL Study Investigators	2001	N Engl J Med2001，345，12：	1
16	Cardiorenal end points in a trial of aliskiren for type 2 diahetes显示文摘	Parring HH Brenner BM McMurray JJ	2012	N Engl J Med2012，367，23：	1
17	Cardiorenal end points in a trial of aliskiren for type 2 diabetes显示文摘	Parring HH Brenner BM MeMurray JJ	2012	N Engl J Med2012，367，23：	1
18	Cardiorenal end points in a trial of aliskiren for type 2 diabetes显示文摘	Parving HH Brenner BM McMurray JJ	2012	N Engl J Med2012，367，23：	1
19	The kidney M显示文摘	Parring HH Mauer M Ritz E Diabetic Nepht'opathy A Brenner BM	2004	Philadelphia:Sau nder2004，，：	1
20	Metabolic activation of islet cells improves resistance against oxygen radicals or streptozocin, but not nitric oxide 显示文摘	Burkart V Brenner HH Hartmann B	1996	J Clin Endocrinol Metab1996，81，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示